Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma
Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma
About this item
Full title
Author / Creator
Rao, Dipti , van Berkel, Anouk , Piscaer, Ianthe , Young, William F , Gruber, Lucinda , Deutschbein, Timo , Fassnacht, Martin , Beuschlein, Felix , Spyroglou, Ariadni , Prejbisz, Aleksander , Hanus, Katarzyna , Eisenhofer, Graeme , Manelli, Massimo , Canu, Letizia , Lenders, Jacques W M , Bancos, Irina and Timmers, Henri J L M
Publisher
Washington, DC: Endocrine Society
Journal title
Language
English
Formats
Publication information
Publisher
Washington, DC: Endocrine Society
Subjects
More information
Scope and Contents
Contents
Abstract
Context
Cross-sectional imaging with CT or MRI is regarded as a first-choice modality for tumor localization in patients with pheochromocytoma and paraganglioma (PPGL). 123I-labeled metaiodobenzylguanidine (123I-MIBG) is widely used for functional imaging but the added diagnostic value is controversial.
Objective
To establish t...
Alternative Titles
Full title
Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2187519469
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2187519469
Other Identifiers
ISSN
0021-972X
E-ISSN
1945-7197
DOI
10.1210/jc.2018-02355
